VitalTrace has had the pleasure of participating in iPREP WA's Industry and PhD Research and Engagement Program. We were fortunate to work with our very own “Dream Team”; Alvin Lee, Saman Akbar Zadeh and Georgios Mavropalias, bringing their expertise in signal processing, data science and biomedical science respectively.
No items found.
No items found.
$2.85M successful CRC-P grant win for VitalTrace
VitalTrace and our associated partners are honoured to announce that our CRC-P bid has been successfully awarded a $2.85M grant from the Commonwealth.
August 9, 2021
•
3 min read
VitalTrace and our associated partners are honoured to announce that our CRC-P bid has been successfully awarded a $2.85M grant from the Commonwealth. This grant highlights the importance of improving the standard of care delivered to mothers and babies during the childbirth process, and will fund integral research and development milestones.
We are excited by the opportunity this funding presents to improve the future of childbirth monitoring, with a total project value of $11.3M and a world class team of researchers and innovators.
Thank you to our key supporters to date and everyone that supported this successful bid, particularly Danica Sekulovska GAICD and McGarry House.
CRC-Ps strengthen links between research organisations and industry, to develop new technologies, products, processes and services. For more information, and to see the list of successful projects, visit business.gov.au/crc-p
No items found.
VitalTrace's first peer-reviewed journal article published in The SMFM Pregnancy Journal
Our first peer-reviewed journal article has been published in The SMFM Pregnancy Journal — the official open-access journal of the Society for Maternal-Fetal Medicine (SMFM) based in Washington, DC.
June 6, 2025
•
3 min read
Our first peer-reviewed journal article has been published in The SMFM Pregnancy Journal — the official open-access journal of the Society for Maternal-Fetal Medicine (SMFM) based in Washington, DC.
In collaboration with The University of Western Australia, our study demonstrates the capability of our technology, DelivAssure, in detecting early signs of fetal lactic acidosis, highlighted by the strong correlation between sensor current and venous blood lactate levels.
We're proud to contribute to the growing body of evidence aimed at improving outcomes for mothers and babies — DelivAssure has the potential to revolutionise intrapartum care by enabling crucial early detection and management of fetal asphyxia during labor and delivery.
📰 Read the full article here: https://onlinelibrary.wiley.com/doi/10.1002/pmf2.70017
We're incredibly grateful to our collaborators, clinical partners, and the SMFM editorial team for supporting this work.
No items found.
Using technology for better obstetric decision making
A wonderful feature from one of VitalTrace's clinical and commercial advisors, Vinayak Smith, on the role of innovative technologies to reduce the risk of litigation in obstetrics!
September 24, 2020
•
3 min read
A wonderful feature from one of VitalTrace's clinical and commercial advisors, Vinayak Smith, on the role of innovative technologies to reduce the risk of litigation in obstetrics!
“Cardiotocography (CTG) has been used for foetal heartrate (FHR) surveillance since the 1970s, as a means of detecting foetal hypoxia and guiding clinical decisions around delivery timing.
Despite the length of its usage, there is yet to be convincing evidence that CTG reduces birth asphyxia, stillbirths, caesareans or instrumental deliveries.
Although the technology is good at providing reassurance when foetal heartrates are ‘normal’, it is less useful at working out the prognosis of ‘abnormal’ heartrates, explains Dr. Vinayak Smith, of Monash University and the Royal Australian and New Zealand College of Obstetricians and Gynaecologists.
“It is not easy for two clinicians to agree or interpret the same CTG output the same way,” said Dr. Smith ahead of the Obstetric Malpractice Conference.
“Heartrates which look normal are easy to trust, whereas abnormal ones could mean anything. The CTG doesn’t tell us how worried we should be when a heartrate doesn’t look quite right.
“As a result, FHR red flags can be wrongfully dismissed by the clinician, leading to ‘preventable’ delivery complications or, in extreme cases, foetal deaths.
“Conversely, false alarms can lead to unnecessary clinical intervention and greater numbers of (precautionary) C-sections – a procedure which is risky for both mother and baby.”
Aside from the risk of healthcare complications, CTG reliability issues expose clinicians to legal culpability.
With 20 percent of obstetrics claims involving CTG – and obstetrics accounting for a significant proportion of medico legal disputes – it is widely agreed that better foetal monitoring solutions are needed.”